WuXi Biologics (2269.HK), a prominent global Contract Research, Development, and Manufacturing Organization (CRDMO), has proudly announced its recognition for exemplary corporate transparency and commitment to water security by the esteemed…
UCB, a leading global biopharmaceutical company, has announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a favorable opinion,…
In a strategic move towards advancing regenerative agriculture, Bayer has announced a partnership with Trinity Agtech, a UK-based company. This collaboration aims to leverage Trinity Agtech’s platform, Sandy, as a…
Legend Biotech Corporation (NASDAQ: LEGN), a leading global figure in cell therapy, has unveiled its inaugural Environmental, Social & Governance (ESG) report. This comprehensive document provides an insight into Legend…
Viatris Inc. recently concluded agreements for a comprehensive global research and development collaboration with Idorsia Ltd (SIX: IDIA), a transaction that was finalized on March 15, 2024. For detailed information…
WuXi Biologics announced a USD$1.4 billion (S$2 billion) investment in Singapore in 2022. The CRDMO center will be the first-of-its-kind in Singapore, offering end-to-end biologics research, development and manufacturing solutions…
Labcorp, a leading provider of cutting-edge laboratory services, has unveiled its latest breakthrough: a test capable of detecting phosphorylated tau 217 (pTau217) in the blood. This innovative biomarker serves as…
A woman in her 50’s has frequently had enough knowledge in relationships to know what she wants and is n’t willing to settle. She is usually done making the same…
Pfizer Inc. (NYSE: PFE) has disclosed promising findings from a Phase 3 clinical trial investigating the efficacy of the antibody-drug conjugate ADCETRIS® (brentuximab vedotin) in conjunction with lenalidomide and rituximab…
Roche (SIX: RO, ROG; OTCQX: RHHBY) has announced the successful approval of all proposed resolutions by its shareholders at the Annual General Meeting. The meeting saw 77.02% of the total…
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has announced the successful outcome of the Phase 3 KEYNOTE-A18 trial, also recognized as ENGOT-cx11 This trial…
Merck (NYSE: MRK), also known as MSD outside the United States and Canada, made a significant announcement today at the EUROGIN 2024 HPV Congress. The company revealed its intentions to…